Today, modern biotechs are moving compounds to the clinic at a faster pace than ever before. As a result, many companies struggle with the transition from an R&D culture to a more-structured, regulated one. Some of their challenges include implementing regulated systems, policies, and strategies. Crossing this chasm requires updating nearly everything from software to org charts to documentation.
In this webinar, you will hear a detailed overview of process, data, personnel and cultural characteristics of clinical stage biotechs.
What you will learn:
The key changes prompted by becoming a clinical-stage biotech